메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Kwon, Yi-Hong (Department of Biomedical Science, Laboratory for Functional Foods & Nutrigenomics, Department of Food Science and Biotechnology, CHA University) Lee, Jun-Hee (Laboratory for Vascular Medicine & Stem Cell Biology, Research Institute of Convergence of Biomedical Science and Technology, Department of Physiology, Pusan National University Yangs) Jung, Seok-Yun (Laboratory for Vascular Medicine & Stem Cell Biology, Research Institute of Convergence of Biomedical Science and Technology, Department of Physiology, Pusan National University Yan) Kim, Jae-Won (Department of Biomedical Science, Laboratory for Functional Foods & Nutrigenomics, Department of Food Science and Biotechnology, CHA University) Lee, Sang-Hun (Laboratory for Vascular Medicine & Stem Cell Biology, Research Institute of Convergence of Biomedical Science and Technology, Department of Physiology, Pusan National University Yang) Lee, Dong-Hyung (Department of Obstetrics and Gynecology, Pusan National University College of Medicine and Medical Research Institute) Lee, Kyu-Sup Lee, Boo-Yong Kwon, Sang-Mo
저널정보
한국응용약물학회 Biomolecules & Therapeutics(구 응용약물학회지) Biomolecules & therapeutics 제20권 제2호
발행연도
2012.1
수록면
158 - 164 (7page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Inhibiting the bioactivities of circulating endothelial progenitor cells (EPCs) results in significant inhibition of neovessel formation during tumor angiogenesis. To investigate the potential effect of phloroglucinol as an EPC inhibitor, we performed several in vitro functional assays using $CD34^+$ cells isolated from human umbilical cord blood (HUCB). Although a high treatment dose of phloroglucinol did not show any cell toxicity, it specifically induced the cell death of EPCs under serum free conditions through apoptosis. In the EPC colony-forming assay (EPC-CFA), we observed a significant decreased in the small EPC-CFUs for the phloroglucinol group, implying that phloroglucinol inhibited the early stage of EPC commitment. In addition, in the in vitro expansion assay using $CD34^+$ cells, treatment with phloroglucinol was shown to inhibit endothelial lineage commitment, as demonstrated by the decrease in endothelial surface markers of EPCs including $CD34^+$, $CD34^+/CD133^+$, $CD34^+/CD31^+$ and $CD34^+/CXCR4^+$. This is the first report to demonstrate that phloroglucinol can inhibit the functional bioactivities of EPCs, indicating that phloroglucinol may be used as an EPC inhibitor in the development of biosafe anti-tumor drugs that target tumor angiogenesis.

목차

등록된 정보가 없습니다.

참고문헌 (18)

참고문헌 신청

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0